Individual holder
PUSCHETT JULES B
US·3 granted patents·8 pending applications·2 citations·filing 2004–2018
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
11 records- 0166US8642568B2Method of diagnosing and therapeutically treating a patient for a traumatic brain injuryPUSCHETT JULES B·Filed 2011·Granted Feb 4, 2014·2 cites·8 claims
- 0258US10514377B2Method of diagnosing and therapeutically treating a patient for a traumatic brain injuryPUSCHETT JULES B·Filed 2014·Granted Dec 24, 2019·0 cites·2 claims
- 0351US2008146592A1Method of Treating Preeclampsia Employing MetolazonePUSCHETT JULES B·Filed 2004·Application pending·0 cites
- 0446US8080539B2Method of treating human preeclampsia employing resibufageninPUSCHETT JULES B·Filed 2010·Granted Dec 20, 2011·0 cites·18 claims
- 0546US2015157647A1Methods and compositions related to acute respiratory distress syndromePUSCHETT JULES B·Filed 2014·Application pending·0 cites
- 0645US2008299602A1Methods of Employing Vascular Leakage to Diagnose a Capillary Leak DisorderPUSCHETT JULES B·Filed 2008·Application pending·0 cites
- 0741US2018340947A1Involvement of the bufodienolides in the diagnosis and treatment of post-traumatic stress disorder (ptsd)PUSCHETT JULES B·Filed 2018·Application pending·0 cites
- 0836US2016299130A1Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress SyndromePUSCHETT JULES B·Filed 2016·Application pending·0 cites
- 0936US2011044963A1Method of Testing a Patient for Hypertension and Related Method of Treatment and Test KitPUSCHETT JULES B·Filed 2010·Application pending·0 cites
- 1035US2016120881A1Use of bufodienolides in diagnosing and treating essential hypertensionPUSCHETT JULES B·Filed 2015·Application pending·0 cites
- 1134US2015338397A1Use of Bufodienolides in Diagnosing and Treating Essential HypertensionPUSCHETT JULES B·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PUSCHETT JULES B files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →